Capital-raising platform · Est. 2025
A considered bridge between investors and breakthrough ventures.
Opportunity-Plus Investment Fund connects institutional, accredited, and high-net-worth investors with carefully vetted opportunities in pharma and agribiotech — underwritten by decades of capital markets discipline.
About the fund
Bridging Vision and Capital
Opportunity-Plus Investment Fund (OPIF) is a premier capital-raising platform that forms the bridge between innovative creators and strategic investors. We specialize in the pharmaceutical and agribiotech industries, helping bring cutting-edge solutions to life through secure funding opportunities.
Investment philosophy
Long-term value over short-term noise.
We focus on sustainable growth opportunities across healthcare, agritech, and emerging markets — emphasising long-term value creation and risk-adjusted returns over speculative upside.
Our partner network of family offices, institutional partners, and accredited investors gives us access to exclusive opportunities most platforms never see.
Featured opportunities
Current fund ventures
Implicit Bioscience
Clinical-stage biotech developing IC14, a monoclonal antibody targeting inflammatory and neurodegenerative conditions, founded 2005.
View Fund →
Anti Ordinary
Next-generation helmet technology validated as the safest all-mountain helmet ever tested by the Virginia Tech Helmet Lab.
View Fund →
Artemis Structural Intelligence
Clinical-stage biotech developing IC14, a monoclonal antibody targeting inflammatory and neurodegenerative conditions, founded 2005.
View Fund →
Get started
Ready to review the current
opportunities?
Speak with our team about accreditation requirements
and current capital-raising rounds.
Opportunity-Plus Investment Fund
Connecting institutional, accredited, and high-net-worth investors with carefully vetted opportunities across pharma and agribiotech.
Contact
© 2026 Opportunity-Plus Investment Fund (OPIF). All rights reserved.